UPC Analytics
ENDE
Overview · Filed:

ACT_16116/2024

NOVEL ANTITUMORAL USE OF CABAZITAXEL

InfringementMain Infringement ActionMunich LDInfringement Action
Substantive event Case management AppellateDotted = low-confidence date
procedural_only
Sep 15, 20
Oral hearing scheduled
Oct 14, 20